Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reducing the number and site of botulinum toxin injections in overactive bladder
IRCT20240504061648N3Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox in overactive bladder (OAB), sponsored by Tabriz University of Medical Sciences. Started Nov 2025; status: completed.
02
Drugs
neuronox
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on IRCT20240504061648N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240504061648N3.